GynecologyGynecology2079-56962079-5831Consilium Medicum27593Research ArticleKontratseptivnaya i lechebnaya effektivnost' "Yariny" u zhenshchin s predmenstrual'nym sindromomKuznetsovaI V-SumyatinaL V-151220046631031209042020Copyright © 2004, Consilium Medicum2004предменструальный синдромкомбинированные оральные контрацептивыдроспиренонЯрина[Smith S.S. Premenstrual steroids. Cell Mol Life Sci 2001; 58: 1263–75.][Monteleone P, Luisi S, Tonetti A et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000; 142: 269–73.][Steiner M, Dunn E.J. The psychobiology of female - specific mood disorders. Infertil Reprod Med Clin North Am 1996; 7: 297–313.][Rapkin A.J, Morgan M, Goldman N et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997; 90: 790–814.][Feuerstein M, Shaw W.S. Measurement properties of the calendar of premenstrual experience in patient with premenstrual syndrome. J Reprod Med 2002; 47: 279–89.][Тихомиров А.Л., Олейник Ч.Г. Предменструальный синдром. Трудный пациент. 2004; 2 (2): 38–42.][Прилепская В.Н., Волобуев А.И., Швецова О.Б. Масталгия у женщин репродуктивного возраста: клиника, диагностика, лечение. Гинекология. 2003; 5 (4): 161–5.][Евсеев А.А. Влияние орального контрацептива “Мерсилон” на массу тела пациенток. Гинекология. 2002; 3 (4): 150–2.][Lombardi I, Luisi S, Quirici B et al. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol Endocrinol 2004; 18: 79–87.][Freeman E.W, Frye C.A, Rickels K et al. Allopregnenalone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 2002; 22: 516–20.][Bloch M, Schmidt P.J, Su T.P et al. Pituitary - adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry 1998; 43: 897–903.]